Full text is available at the source.
Abstract
The study aims to develop a composite lyoprotectant to enhance the stability of the RPA-CRISPR-Cas12a system for respiratory pathogen detection.
- Acute respiratory infections caused by bacterial and viral pathogens represent a significant global health challenge.
- Current point-of-care testing using the RPA-CRISPR-Cas12a system is limited by the instability of its lyophilized reagents.
- Improving the stability of these reagents could facilitate the field deployment of rapid diagnostic tests for respiratory pathogens.
Simplified